These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


235 related items for PubMed ID: 3603414

  • 1. Monitoring heparin therapy by the activated partial thromboplastin time--the effect of pre-analytical conditions.
    van den Besselaar AM, Meeuwisse-Braun J, Jansen-Grüter R, Bertina RM.
    Thromb Haemost; 1987 Apr 07; 57(2):226-31. PubMed ID: 3603414
    [Abstract] [Full Text] [Related]

  • 2. A low volume specimen container suitable for monitoring the aPTT of heparinized patients.
    Ray MJ, Carroll PA, Just SJ, Hawson GA.
    Blood Coagul Fibrinolysis; 1993 Oct 07; 4(5):805-7. PubMed ID: 8292732
    [Abstract] [Full Text] [Related]

  • 3. [Theophylline adenosine dipyridamole (CTAD) and citrate evaluation to survey unfractionated heparin treatment: a delayed centrifugation validation for anti-Xa measurement?].
    Billoir P, Clavier T, Guilbert A, Barbay V, Chrétien MH, Fresel M, Abriou C, Girault C, Le Cam Duchez V.
    Ann Biol Clin (Paris); 2020 Feb 01; 78(1):27-34. PubMed ID: 32108577
    [Abstract] [Full Text] [Related]

  • 4. Is citrate theophylline adenosine dipyridamole (CTAD) better than citrate to survey unfractionated heparin treatment? Has delayed centrifugation a real impact on this survey?
    Billoir P, Clavier T, Guilbert A, Barbay V, Chrétien MH, Fresel M, Abriou C, Girault C, Le Cam Duchez V.
    J Thromb Thrombolysis; 2019 Aug 01; 48(2):277-283. PubMed ID: 31098816
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Monitoring heparin therapy by thrombin time and activated partial thromboplastin time--a comparison].
    Lang M, Fey MF, Furlan M, Beck EA.
    Schweiz Med Wochenschr; 1986 Nov 29; 116(48):1681-4. PubMed ID: 3798064
    [Abstract] [Full Text] [Related]

  • 7. The effect of aprotinin on the response of the activated partial thromboplastin time (APTT) to heparin.
    Francis JL, Howard C.
    Blood Coagul Fibrinolysis; 1993 Feb 29; 4(1):35-40. PubMed ID: 7681330
    [Abstract] [Full Text] [Related]

  • 8. Standardization of coagulation tests.
    Opartkiattikul N.
    Southeast Asian J Trop Med Public Health; 1999 Feb 29; 30 Suppl 3():79-85. PubMed ID: 10926265
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effects of heparin on the activated partial thromboplastin time of the College of American Pathologists Survey specimens. Responsiveness, precision, and sample effects.
    Gawoski JM, Arkin CF, Bovill T, Brandt J, Rock WA, Triplett DA.
    Arch Pathol Lab Med; 1987 Sep 29; 111(9):785-90. PubMed ID: 3632297
    [Abstract] [Full Text] [Related]

  • 11. The therapeutic range for heparin therapy: relationship between six activated partial thromboplastin time reagents and two heparin assays.
    Kitchen S, Preston FE.
    Thromb Haemost; 1996 May 29; 75(5):734-9. PubMed ID: 8725715
    [Abstract] [Full Text] [Related]

  • 12. The uncalibrated prothrombinase-induced clotting time test. Equally convenient but more precise than the aPTT for monitoring of unfractionated heparin.
    Korte W, Jovic R, Hollenstein M, Degiacomi P, Gautschi M, Ferrández A.
    Hamostaseologie; 2010 Nov 29; 30(4):212-6. PubMed ID: 21057708
    [Abstract] [Full Text] [Related]

  • 13. Activated coagulation time in monitoring heparinized dogs.
    Green RA.
    Am J Vet Res; 1980 Nov 29; 41(11):1793-7. PubMed ID: 7212408
    [Abstract] [Full Text] [Related]

  • 14. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
    Taneja R, Marwaha G, Sinha P, Quantz M, Stitt L, Gao R, Subramanian S, Schaus M, Keeney M, Chin-Yee I, Murkin J.
    Can J Anaesth; 2009 Jul 29; 56(7):489-96. PubMed ID: 19408066
    [Abstract] [Full Text] [Related]

  • 15. Measurement of prothrombin time (PT) and activated partial thromboplastin time (APTT) on canine citrated plasma samples following different storage conditions.
    Rizzo F, Papasouliotis K, Crawford E, Dodkin S, Cue S.
    Res Vet Sci; 2008 Aug 29; 85(1):166-70. PubMed ID: 17998140
    [Abstract] [Full Text] [Related]

  • 16. The effect of time and temperature variables on routine coagulation tests.
    Adcock D, Kressin D, Marlar RA.
    Blood Coagul Fibrinolysis; 1998 Sep 29; 9(6):463-70. PubMed ID: 9818995
    [Abstract] [Full Text] [Related]

  • 17. On the value of the activated partial thrombo-plastin time (aptt) in monitoring heparin therapy.
    Teien AN, Abildgaard U.
    Thromb Haemost; 1976 Jun 30; 35(3):592-7. PubMed ID: 989966
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.